MELANOMA2009-2013

JOHNS HOPKINS HOSPITAL

CANCER REGISTRY

Prepared by Theresa SanLorenzo-Caswell, CTR10/16/20014

HEAD/NECK OF THE SKINANALYTIC vs. NON-ANALYTIC by YEARN = 1800

2009 2010 2011 2012 2013

ANALYTIC (1645) 355 334 301 303 352

NON-ANALYTIC (196) 39 47 35 36 39

25

75

125

175

225

275

325

375

NU

MB

ER

MELANOMA2009-2013 ALL CASES = 1841ANALYTIC vs. NON-ANALYTIC

HEAD/NECK OF THE SKINAGE AT DIAGNOSIS, ALL CASESN = 1800

0 - 19 20 - 29 30 - 39 40 - 49 50 - 59 60 - 69 70 - 79 80+

MALE (1010) 7 25 63 95 238 272 211 99

FEMALE (1246) 16 62 99 162 173 164 99 56

25

75

125

175

225

275

NU

MB

ER

MELANOMA2009-2013 ALL CASES = 1841AGE AT DIAGNOSIS

MELANOMA2009-2013 ALL CASES = 1841RACE/ETHNICITY

CAUCASIAN AFRICAN AMERICAN HISPANIC OTHER

MALE 994 7 6 3

FEMALE 808 17 4 2

100

300

500

700

900

1100

NU

MB

ER

MELANOMA2009-2013 ALL CASES = 1841STATE OF RESIDENCE AT DIAGNOSIS

MD75.4%

VA8.9%

PA6.2%

DE2.1%

DC1.9%

WV1.6%

NJ0.8% Foreign

0.5%ALL OTHER STATES

2.6%

MELANOMA2009-2013 ALL MARYLAND CASES = 1389COUNTY OF RESIDENCE AT DIAGNOSIS

BALTIMORE CO.25.8%

BALTIMORE CITY12.1%

ANNE ARUNDEL CO.10.9%MONTGOMERY CO.

10.5%

HOWARD CO.8.9%

HARFORD CO.5.6%

FREDERICK CO.5.3%

PRINCE GEORGES CO.4.7%

ALL OTHER COUNTIES16.1%

MELANOMA2009-2013 ANALYTIC CASES = 1636*AJCC STAGE

AJCC 028.8%

AJCC I44.3%

AJCC II11.4%

AJCC III10.9%

AJCC IV3.6%

AJCC UNK0.9%

N/A0.1%

*Excludes Class 0: Diagnosed at JHH only; all treatment elsewhere

MELANOMA2009-2013 ANALYTIC CASES TREATMENT BY STAGE

AJCC 0 (472) AJCC I (724) AJCC II (186) AJCC III (178) AJCC IV (59)

Surgery Only 100 98.6 93.0 53.4 6.8

Radiation Only 0 0 0.5 1.7 11.9

Immunotherapy Only 0 0 0 2.0 28.8

Surgery & Radiation 0 0.1 2.7 3.4 6.8

Surgery & Chemotherapy 0 0 0.5 2.8 3.4

Surgery, Chemotherapy & Immunotherapy 0 0.3 1.1 2.8 0

Surgery & Immunotherapy 0 0.6 2.2 24.0 6.8

Radiation & Immunotherapy 0 0 0 0 0

Other Combinations 0 0.3 0 6.2 27.0

No Treatment 0 0.1 0 3.7 8.5

100% 100% 100% 100% 100%

*Excludes Class 0: Diagnosed at JHH only; all treatment elsewhere

MELANOMA 5-YEAR OBSERVED SURVIVAL 2003-2006JHH vs. SEER vs. NCDB

YR 0 YR 1 YR 2 YR 3 YR 4 YR 5

JHH (213) 1 0.995 0.991 0.986 0.967 0.962

SEER (0) 1 NaN NaN NaN NaN NaN

NCDB (23374) 1 0.988 0.97 0.949 0.928 0.906

85%

87%

89%

91%

93%

95%

97%

99%

AJCC 0

PER

CEN

TAG

E

©2014 NCDB, CoC*©SEER; SEER*STAT – SEER DOES NOT COLLECT MELANOMA INSITU

MELANOMA 5-YEAR OBSERVED SURVIVAL 2003-2006JHH vs. SEER vs. NCDB

YR 0 YR 1 YR 2 YR 3 YR 4 YR 5

JHH (443) 1 0.995 0.989 0.97 0.943 0.924

SEER (26698) 1 0.989 0.973 0.954 0.933 0.913

NCDB (49169) 1 0.989 0.972 0.95 0.929 0.907

87%

89%

91%

93%

95%

97%

99%

AJCC I

PER

CEN

TAG

E

©2014 NCDB, CoC©SEER; SEER*STAT

MELANOMA 5-YEAR OBSERVED SURVIVAL 2003-2006JHH vs. SEER vs. NCDB

YR 0 YR 1 YR 2 YR 3 YR 4 YR 5

JHH (101) 1 0.99 0.88 0.79 0.73 0.7

SEER (4068) 1 0.946 0.865 0.782 0.722 0.669

NCDB (13327) 1 0.945 0.861 0.776 0.713 0.659

5%

15%

25%

35%

45%

55%

65%

75%

85%

95%

AJCC II

PERC

ENTA

GE

©2014 NCDB, CoC©SEER; SEER*STAT

MELANOMA 5-YEAR OBSERVED SURVIVAL 2003-2006JHH vs. SEER vs. NCDB

YR 0 YR 1 YR 2 YR 3 YR 4 YR 5

JHH (96) 1 0.885 0.75 0.698 0.615 0.563

SEER (2452) 1 0.912 0.778 0.677 0.621 0.576

NCDB (8979) 1 0.903 0.759 0.661 0.592 0.541

5%15%25%35%45%55%65%75%85%95%

AJCC III

PERC

ENTA

GE

©2014 NCDB, CoC©SEER; SEER*STAT

MELANOMA 5-YEAR OBSERVED SURVIVAL 2003-2006JHH vs. SEER vs. NCDB

YR 0 YR 1 YR 2 YR 3 YR 4 YR 5

JHH (48) 1 0.479 0.229 0.229 0.167 0.167

SEER (1378) 1 0.378 0.237 0.17 0.143 0.127

NCDB (4579) 1 0.38 0.222 0.172 0.145 0.13

5%15%25%35%45%55%65%75%85%95%

AJCC IV

PERC

ENTA

GE

©2014 NCDB, CoC©SEER; SEER*STAT